Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab.
Cañas A, López-Sánchez LM, Peñarando J, Valverde A, Conde F, Hernández V, Fuentes E, López-Pedrera C, de la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. Cañas A, et al. Among authors: de la haba rodriguez jr. Biochim Biophys Acta. 2016 Apr;1862(4):601-610. doi: 10.1016/j.bbadis.2016.02.005. Epub 2016 Feb 6. Biochim Biophys Acta. 2016. PMID: 26854735 Free article.
Clinical trials: bad combinations or bad designs.
de la Haba-Rodríguez J, Gómez A, Aranda E. de la Haba-Rodríguez J, et al. Clin Transl Oncol. 2005 Nov;7(10):419-20. doi: 10.1007/BF02716591. Clin Transl Oncol. 2005. PMID: 16373049 No abstract available.
Time-to-progression in breast cancer: a stratification model for clinical trials.
de la Haba-Rodríguez J, Aranda E, Llombart A, Lluch A, Alba E, Munárriz B, Adrover E, Tusquets I, Balil A, Barnadas A, Calvo L, Martín M; Grupo Español de Investigación en Cáncer de Mama (GEICAM). de la Haba-Rodríguez J, et al. Breast. 2008 Jun;17(3):239-44. doi: 10.1016/j.breast.2007.09.007. Epub 2007 Nov 26. Breast. 2008. PMID: 18042386
Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007.
de la Haba-Rodríguez J, Alba E, Barnadas A, Bayo E, Llombart A, Lluch A, Martín M, Moreno-Nogueira JA, Pérez Manga G, Rodríguez-Lescure A, Aranda E. de la Haba-Rodríguez J, et al. Clin Transl Oncol. 2008 Sep;10(9):552-9. doi: 10.1007/s12094-008-0250-y. Clin Transl Oncol. 2008. PMID: 18796372
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response.
Sánchez-Rovira P, Seguí MA, Llombart A, Aranda E, Antón A, Sánchez A, Lomas M, Jaén A, Fernández M, Porras I, Dalmau E, Morales S, de la Haba-Rodríguez J. Sánchez-Rovira P, et al. Clin Transl Oncol. 2013 Oct;15(10):810-7. doi: 10.1007/s12094-013-1006-4. Epub 2013 Feb 9. Clin Transl Oncol. 2013. PMID: 23397155 Free PMC article. Clinical Trial.
68 results